cellular
receptor
human
coronaviru
group
coronaviru
angiotensinconvert
also
receptor
sar
coronaviru
sarscov
group
ii
coronaviru
describ
abil
util
number
variant
previous
character
sarscov
receptor
sever
variant
reduc
sarscov
sprotein
associ
similarli
reduc
wherea
alter
number
solventexpos
residu
interfer
bind
either
protein
one
notabl
except
residu
boundari
sarscov
bind
site
whose
alter
markedli
inhibit
util
sarscov
protein
addit
sarscov
sprotein
receptorbind
domain
inhibit
entri
mediat
protein
studi
indic
like
sarscov
associ
region
human
includ
key
loop
form
coronavirus
infect
wide
rang
host
caus
enter
respiratori
neurotrop
disord
human
anim
bastien
et
al
holm
et
al
mcintosh
date
five
human
coronavirus
two
phylogenet
group
character
human
coronavirus
group
group
ii
typic
caus
mild
diseas
estim
respons
common
cold
contribut
seriou
lower
respiratori
tract
infect
contrast
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
winter
fatal
approxim
infect
bastien
et
al
lee
et
al
peiri
et
al
zhong
et
al
human
coronaviru
also
describ
hcovnl
hcovnh
describ
esper
et
al
fouchier
et
al
van
der
hoek
et
al
infect
appear
common
childhood
adult
sera
contain
antibodi
neutral
viru
hofmann
et
al
van
der
hoek
et
al
case
viru
caus
sever
lower
respiratori
tract
infect
requir
hospit
especi
young
children
elderli
immunocompromis
adult
arden
et
al
bastien
et
al
chiu
et
al
ebihara
et
al
gerna
et
al
kaiser
et
al
vabret
et
al
also
report
associ
croup
among
coronavirus
similar
anoth
group
coronaviru
howev
virus
util
distinct
cellular
receptor
util
wherea
util
angiotensinconvert
enzym
receptor
sarscov
group
ii
coronaviru
hofmann
et
al
li
et
al
yeager
et
al
receptor
human
group
ii
coronavirus
identifi
spike
protein
coronavirus
larg
transmembran
glycoprotein
mediat
receptor
associ
membran
fusion
viral
entri
bosch
et
al
colman
lawrenc
gallagh
buchmeier
protein
coronavirus
cleav
two
subunit
cellular
proteas
jackwood
et
al
sturman
holm
sturman
et
al
sarscov
protein
cleav
produc
cell
two
function
distinct
domain
correspond
subunit
cleav
protein
describ
li
et
al
xiao
et
al
domain
mediat
associ
cellsurfac
receptor
wherea
domain
contain
hydrophob
fusion
peptid
coiledcoil
region
orchestr
process
membran
fusion
follow
receptor
associ
bosch
et
al
li
et
al
xiao
dimitrov
discret
independ
fold
receptorbind
domain
rbd
identifi
domain
number
coronavirus
breslin
et
al
kubo
et
al
wong
et
al
first
amino
acid
spike
protein
mous
hepat
viru
mhv
effici
bind
mhv
receptor
dveksler
et
al
kubo
et
al
rbd
protein
locat
residu
breslin
et
al
aminoacid
fragment
sarscov
domain
residu
bind
human
nanomolar
affin
structur
sarscov
rbd
complex
human
reveal
extend
tyrosineenrich
loop
rbd
residu
direct
contact
li
et
al
region
describ
receptorbind
motif
rbm
li
et
al
show
alter
residu
region
protein
similar
rbm
region
sarscov
interf
one
case
enhanc
associ
also
show
protein
sarscov
bind
overlap
region
includ
critic
loop
fourth
fifth
studi
underscor
common
entri
protein
two
diverg
coronavirus
impli
entri
inhibitor
sarscov
may
also
effect
truncat
variant
bind
protein
compos
amino
acid
includ
ntermin
fragment
present
coronavirus
fouchier
et
al
fragment
suggest
contribut
recognit
hofmann
et
al
test
possibl
four
truncat
variant
spike
protein
encod
residu
gener
variant
express
fusion
protein
contain
fc
region
human
previous
describ
li
et
al
wong
et
al
plasmid
encod
fusion
protein
transfect
cell
subsequ
incub
ii
medium
h
protein
purifi
protein
asepharos
bead
fig
protein
incub
cell
transfect
plasmid
express
human
transfect
cell
analyz
flow
cytometri
shown
fig
variant
encod
residu
effici
bound
cell
wherea
variant
encod
thu
import
determin
associ
locat
residu
uniqu
ntermin
region
protein
contribut
receptor
bind
data
consist
previous
report
hofmann
et
al
fig
also
underscor
substanti
higher
effici
sarscov
protein
bind
compar
defin
receptorbind
region
spike
protein
addit
truncat
variant
similarli
made
character
fig
variant
includ
residu
effici
bound
cell
wherea
twelv
addit
smaller
variant
could
detect
bind
cell
variant
consist
bound
cell
less
effici
variant
therefor
residu
amino
acid
make
substanti
contribut
recognit
amino
acid
may
also
contribut
directli
indirectli
receptor
bind
subsequ
assay
util
variant
describ
alter
asparagin
tyrosin
increas
affin
structur
sarscov
rbd
complex
human
determin
li
et
al
rbd
contain
two
subdomain
fivestrand
antiparallel
core
extend
loop
includ
residu
describ
receptorbind
motif
rbm
fourteen
residu
rbm
six
tyrosin
directli
contact
region
residu
align
sarscov
rbm
fig
determin
contribut
region
associ
convert
sever
residu
put
sarscov
equival
case
chang
reduc
associ
howev
alter
asparagin
tyrosin
result
substanti
effici
bind
fig
consist
abil
chang
region
alter
effici
associ
suggest
region
protein
contribut
bind
fig
highlight
sarscov
tyrosin
propos
analog
alter
abil
rat
palm
civet
human
bind
sarscov
protein
compar
previous
li
et
al
sarscov
protein
bind
rat
ineffici
wherea
bind
palm
civet
effici
human
li
et
al
compar
abil
protein
bind
rat
palm
civet
molecul
fig
also
character
two
form
palm
civet
vari
residu
wildtyp
palm
civet
bear
aspart
acid
posit
wherea
anim
includ
human
rat
mous
cat
dog
express
glycin
li
et
al
similar
report
sarscov
bind
rat
effici
bound
form
palm
civet
effici
human
howev
strike
contrast
sarscov
bind
palm
civet
nativ
aspart
acid
residu
therefor
residu
immedi
vicin
glycin
like
contribut
associ
express
residu
smaller
variant
normal
express
coomassi
stain
b
human
igg
residu
indic
truncat
variant
thereof
sarscov
incub
cell
cell
wash
associ
analyz
flow
cytometri
mean
fluoresc
intens
igg
c
experi
similar
panel
b
except
wider
rang
truncat
variant
assay
bind
measur
mean
fluoresc
intens
shown
percentag
bind
observ
compar
abil
human
variant
bind
domain
sarscov
previous
report
introduct
glycosyl
region
rat
residu
denot
mypnf
human
protein
modestli
decreas
bind
sarscov
li
et
al
modif
similarli
decreas
bind
fig
also
introduc
human
four
residu
palm
civet
receptor
result
loss
glycosyl
site
human
receptor
residu
denot
nltvdaki
previous
report
alter
enhanc
sarscov
associ
li
et
al
protein
follow
pattern
howev
introduct
aspart
acid
human
residu
modest
effect
sarscov
associ
wherea
complet
abolish
associ
fig
thu
residu
modul
sprotein
associ
human
palm
civet
fig
b
shown
fig
abil
human
variant
bind
sarscov
reflect
abil
support
infect
mediat
protein
virus
also
character
seri
human
variant
previous
describ
li
et
al
abil
bind
sarscov
support
sarscov
infect
fig
variant
express
effici
indic
antibodi
recognit
ntermin
tag
sever
variant
less
effici
bound
sarscov
domain
also
less
effici
bound
specif
alter
tyrosin
lysin
aspart
acid
arginin
interf
abil
bind
modestli
support
sproteinmedi
infect
also
character
number
alter
solventexpos
residu
previous
shown
interfer
sarscov
associ
none
alter
interf
bind
entri
mediat
protein
supplementari
tabl
collect
data
indic
sarscov
domain
bind
region
larg
overlap
observ
alter
strongli
interfer
bind
sarscov
domain
also
support
assert
residu
immedi
adjac
lysin
residu
critic
associ
sarscov
protein
final
assay
abil
sarscov
rbd
inhibit
infect
mediat
sarscov
fig
alter
put
receptorbind
motif
modul
associ
align
sarscov
rbm
similar
region
protein
sarscov
residu
directli
contact
highlight
sprotein
asparagin
whose
alter
tyrosin
enhanc
associ
residu
whose
alter
decreas
associ
underlin
b
experi
similar
fig
except
variant
alter
put
receptorbind
motif
character
c
structur
sarscov
rbd
bound
white
rbm
shown
light
grey
rbm
residu
direct
contact
shown
black
disulfid
form
small
loop
may
similar
loop
indic
tyrosin
adjac
ctermin
cystein
loop
repres
sphere
fig
sarscov
protein
bind
similar
site
human
cell
express
ntermin
tag
form
human
rat
two
variant
palm
civet
protein
incub
antitag
antibodi
cell
wash
analyz
flow
cytometri
result
indic
percentag
mean
fluoresc
intens
observ
cell
express
human
incub
antitag
antibodi
b
experi
similar
except
human
three
indic
variant
thereof
analyz
bind
antitag
antibodi
sarscov
c
lentivirus
express
luciferas
pseudotyp
protein
sarscov
incub
cell
transfect
human
indic
human
variant
previous
describ
li
et
al
sui
et
al
entri
measur
luciferas
activ
shown
percentag
observ
wildtyp
human
experi
similar
b
c
except
human
variant
proxim
sarscov
bind
site
character
express
bind
sproteinmedi
infect
protein
fig
sarscov
rbd
specif
inhibit
sproteinmedi
infect
previous
report
rbd
also
block
entri
mediat
sarscov
protein
consist
data
fig
observ
indic
protein
util
residu
occlud
sarscov
rbd
reduc
abil
sarscov
rbd
inhibit
entri
mediat
protein
rel
sarscov
protein
may
reflect
bind
site
greater
role
cellular
protein
note
neither
lower
affin
ig
inhibit
entri
mediat
protein
sarscov
concentr
use
fig
shown
fig
summar
observ
virusey
view
human
highlight
residu
critic
protein
virus
close
relat
number
group
virus
found
anim
fouchier
et
al
hofmann
et
al
pyrc
et
al
van
der
hoek
et
al
group
coronavirus
util
cellular
receptor
surprisingli
util
receptor
use
sarscov
hofmann
pohlmann
hofmann
et
al
smith
et
al
although
domain
sarscov
quit
differ
region
sarscov
directli
contact
rbm
bear
similar
region
present
group
coronavirus
includ
region
present
group
ii
coronavirus
sarscov
interestingli
protein
sarscovlik
virus
found
bat
lack
much
region
li
et
al
li
et
al
establish
whether
region
delet
bat
virus
whether
sarscov
acquir
region
perhap
converg
evolut
recombin
group
rel
data
somewhat
consist
acquisit
rbm
sarscov
evolut
shown
perturb
rbmlike
region
protein
interfer
abil
mediat
viral
entri
interestingli
residu
found
rbm
sarscov
introduc
weakli
homolog
region
protein
affin
protein
substanti
enhanc
although
level
observ
sarscov
protein
also
shown
entri
sensit
chang
interfer
adjac
residu
critic
sarscov
entri
addit
sarscov
rbd
inhibit
sproteinmedi
infect
data
indic
sarscov
bind
site
overlap
contrast
hoffman
et
al
use
differ
panel
variant
tent
conclud
virus
distinct
bind
site
identifi
variant
interf
sarscov
entri
hofmann
et
al
shown
variant
previous
shown
limit
sarscov
entri
li
et
al
contact
sarscov
rbd
also
limit
infect
addit
two
variant
loop
form
strand
especi
adjac
lysin
substanti
fig
residu
critic
associ
virusey
view
human
surfac
shown
residu
contact
sarscov
rbd
indic
yellow
orang
residu
whose
alter
affect
hcovcov
bind
color
orang
glycin
whose
alter
aspart
acid
abolish
bind
sarscov
shown
purpl
residu
whose
alter
alter
associ
either
protein
shown
green
green
residu
list
supplementari
tabl
visibl
view
fig
sarscov
rbd
inhibit
sproteinmedi
infect
lentivirus
express
luciferas
pseudotyp
protein
sarscov
incub
cell
presenc
indic
concentr
affin
purifi
goat
antibodi
sarscov
rbdig
human
igg
infect
express
percentag
luciferas
activ
observ
absenc
inhibitor
interf
infect
use
similar
region
may
result
function
constraint
viral
entri
may
reflect
common
origin
receptorbind
motif
diverg
virus
observ
sarscov
bind
similar
region
also
practic
implic
small
molecul
bind
inhibit
sarscov
infect
also
like
inhibit
replic
although
viru
circul
human
popul
modestli
pathogen
case
inhibitor
may
use
treat
subset
seriou
case
pathogen
form
viru
plasmid
encod
codonoptim
form
sarscov
sprotein
isol
access
number
protein
previous
describ
li
et
al
moor
et
al
plasmid
encod
domain
residu
receptorbind
domain
residu
protein
fuse
fc
domain
human
rbdig
respect
previous
describ
wong
et
al
plasmid
encod
domain
gener
insert
codonoptim
sequenc
encod
residu
ident
vector
use
express
sarscov
uniqu
nhei
bamhi
site
sequenc
encod
truncat
variant
gener
pcr
ligat
site
vector
variant
gener
mutagenesi
use
quikchang
method
invitrogen
human
rat
palmcivet
molecul
variant
thereof
encod
aminotermin
tag
cmyc
previous
describ
li
et
al
associ
variant
variant
determin
flow
cytometri
flow
cytometri
use
cell
previous
describ
wong
et
al
briefli
cell
transfect
plasmid
encod
variant
vector
alon
two
day
posttransfect
cell
detach
mm
edta
wash
bsa
variant
thereof
antitag
antibodi
ad
cell
mixtur
incub
ice
h
cell
wash
three
time
bsa
incub
min
ice
antihuman
igg
fitc
conjug
sigma
cell
wash
bsa
analyz
infect
assay
lentiviru
express
luciferas
report
gene
pseudotyp
sarscov
protein
previous
describ
sui
et
al
briefli
cell
cotransfect
plasmid
encod
fulllength
protein
plasmid
encod
gagpol
plasmid
phivluc
encod
firefli
luciferas
report
gene
control
long
termin
repeat
two
day
posttransfect
viral
supernat
harvest
sproteinpseudotyp
viru
use
infect
cell
plate
vari
concentr
sarscov
human
igg
affinitypurifi
polyclon
antibodi
r
system
infect
effici
quantifi
measur
luciferas
activ
target
cell
eg
g
berthold
micropl
luminomet
lb
